TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Thermo Fisher Diagnostics AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
209,015
|
184,270
|
213,444 |
Financial expenses |
2,672
|
4,721
|
1,150 |
Earnings before taxes |
9,823
|
1,506
|
207 |
EBITDA |
11,164
|
10,012
|
14,061 |
Total assets |
62,678
|
49,496
|
393,805 |
Current assets |
60,270
|
45,580
|
34,015 |
Current liabilities |
14,168
|
11,858
|
355,523 |
Equity capital |
48,510
|
37,638
|
38,282 |
- share capital |
101
|
95
|
98 |
Employees (average) |
30
|
29
|
31 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
77.4%
|
76.0%
|
9.7% |
Turnover per employee |
6,967
|
6,354
|
6,885 |
Profit as a percentage of turnover |
4.7%
|
0.8%
|
0.1% |
Return on assets (ROA) |
19.9%
|
12.6%
|
0.3% |
Current ratio |
425.4%
|
384.4%
|
9.6% |
Return on equity (ROE) |
20.2%
|
4.0%
|
0.5% |
Change turnover |
11,669
|
-22,759
|
25,216 |
Change turnover % |
6%
|
-11%
|
13% |
Chg. No. of employees |
1
|
-2
|
6 |
Chg. No. of employees % |
3%
|
-6%
|
24% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.